Express Scripts Holding Co $74.87

up +0.67


20/8/2014 04:00 PM  |  NASDAQ : ESRX  
Industries : Health Services / Health Care Plans
Get Trend Analysis Icon Get ESRX Trend Analysis - it has underperformed the S&P 500 by 4%

Partner Headlines

  1. Air Methods Navigates To Grow Medical Flight Business

    IBD
  2. Buyback ETF Slow-Footed: Better Ideas Here

    YCharts
  3. Without Its Tax Dodge, What’s Walgreen Worth?

    YCharts
  4. The Stocks Already in Correction Mode

    FoxBusiness
  5. Shares Of Express Scripts Up 5% Following Q2 Earnings

    Benzinga
  6. Quarterly “Beats”: Bah, Here Are Real Growers

    YCharts
  7. #PreMarket Primer: Tuesday, July 29: Russia Accused Of Violating Nuclear ...

    Benzinga
  8. Earnings Scheduled For July 29, 2014

    Benzinga
  9. Horizon Pharma Drugs Ditched By Pharmacies; Stock Falls

    IBD
  10. Is Walgreen Set For A Better 2014?

    GuruFocus
  11. Morning Market Losers

    Benzinga
  12. Benzinga's Top #PreMarket Losers

    Benzinga
  13. Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses

    Benzinga
  14. Dodge & Cox Second Quarter 2014 Commentary

    GuruFocus
  15. #PreMarket Primer: Friday, July 18: Tension Between Russia And The West ...

    Benzinga
  16. Walgreen Tax Inversion: Masking A Weak Business?

    YCharts
  17. Merck, Gilead Lead Race To Eradicate Hepatitis C

    IBD
  18. Mid-Year Report Part Two: Not All Stocks Overpriced

    YCharts
  19. Walgreen, Rite Aid Comp Sales Beat On Pharmacies

    IBD
  20. Market Rarity: Great Company at Very Good Price

    YCharts
  21. Weekly CEO Sells Highlight: Installed Building Products Inc, Express Scripts, ...

    GuruFocus
  22. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  23. Rite Aid Lowers Outlook On Drug Costs; Shares Fall

    IBD
  24. Walgreen Soars On Bigger Baskets, Scripts In May

    IBD
  25. Standout In Pharma Supply Chain’s Growth Story

    YCharts
  26. Walgreen Shares Climb Sharply in Holiday-Lifted April

    IBD
  27. Walgreen Hits Record Close On Sweet Easter Sales

    IBD
  28. Novo Nordisk lowers outlook

    IBD
  29. Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss

    IBD
  30. Market Wrap For May 1: Markets Mixed To Start The New Month

    Benzinga
  31. Novo Nordisk Q1 Revenue Misses; Guidance Lowered

    IBD
  32. CVS Retail, Buyback Expected To Boost Q1 Earnings

    IBD
  33. Nasdaq Leads Early Stock Slide; Twitter Tumbles, Trinity Rises

    IBD
  34. Morning Market Losers

    Benzinga
  35. Stock Futures Drag Toward Open; Twitter, VistaPrint Tumble

    IBD
  36. Benzinga's Top #PreMarket Losers

    Benzinga
  37. Market Wrap For April 29: Dow Approaches Record Highs Despite Ongoing Ukraine ...

    Benzinga
  38. #PreMarket Primer: Tuesday, April 29: US Steps Up Sanctions Against Russia

    Benzinga
  39. AbbVie Beats Q1 Estimates, Downplays HCV 'Price War'

    IBD
  40. Gilead, Illumina Q1 Earnings Win Wall Street's Love

    IBD
  41. Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings

    IBD
  42. UnitedHealth Earnings Drop on ObamaCare, Medicare Cuts

    IBD
  43. Funds Buying UnitedHealth: Stunning Div Growth

    YCharts
  44. House Probe Of Gilead's Sovaldi Price Hits Biotechs

    IBD
  45. Gilead Pricing Probed By House; Biotech Stocks Drop

    IBD
  46. Weekly Insider Sells Highlight: JAZZ, HD, ESRX, SCI

    GuruFocus
  47. Google, Ebay: Why A Top Mutual Fund Likes Them

    IBD
  48. Top 4 Large-Cap Stocks In The Health Care Plans Industry With The Highest ...

    Benzinga
  49. UPDATE: Morgan Stanley Reiterates on Express Scripts Following Investor ...

    Benzinga
  50. Stock Market Erases Gains, Closes With Losses

    IBD
Trading Center